Edmund V Capparelli (Edmund Capparelli)

Years Active: 2018-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Roger L Shapiro, Globahan Ajibola, Kenneth Maswabi, Michael Hughes, Bryan S Nelson, Aischa Niesar, Molly Pretorius Holme, Kathleen M Powis, Maureen Sakoi-Mosetlhi, Oganne Batlang, Sikhulile Moyo, Terence Mohammed, Comfort Maphorisa, Kara Bennett, Zixin Hu, Francoise Giguel, Jacqueline D Reeves, Michael A Reeves, Ce Gao, Xu G Yu, Margaret E Ackerman, Adrian B McDermott, Marlene Cooper, Marina Caskey, Lucio Gama, Patrick Jean-Philippe, Dwight E Yin, Edmund V Capparelli, Shahin Lockman, Joseph Makhema, Daniel R Kuritzkes, Mathias D Lichterfeld
Broadly neutralizing antibody treatment maintained HIV suppression in children with favorable reservoir characteristics in Botswana. Science translational medicine 15 (703) (2023)
Martin R Gaudinski, Emily E Coates, Katherine V Houser, Grace L Chen, Galina Yamshchikov, Jamie G Saunders, LaSonji A Holman, Ingelise Gordon, Sarah Plummer, Cynthia S Hendel, Michelle Conan-Cibotti, Margarita Gomez Lorenzo, Sandra Sitar, Kevin Carlton, Carolyn Laurencot, Robert T Bailer, Sandeep Narpala, Adrian B McDermott, Aryan M Namboodiri, Janardan P Pandey, Richard M Schwartz, Zonghui Hu, Richard A Koup, Edmund V Capparelli, Barney S Graham, John R Mascola, Julie E Ledgerwood, null null
Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults. PLoS medicine 15 (1) (2018)

Edmund V Capparelli.css-eqlu8i{font-size:small;padding-left:4px;} (Edmund Capparelli)